Short chain PEGylation of amino acid monomers glutamine, lysine and peptides formed thereby

US10280194B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10280194-B2
Application numberUS-201515317208-A
CountryUS
Kind codeB2
Filing dateJun 8, 2015
Priority dateJun 9, 2014
Publication dateMay 7, 2019
Grant dateMay 7, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Novel synthesized amino acids of glutamine and lysine that are directly PEGylated with small, monodisperse PEGs, and a novel process for creating novel amino acid monomers using PEGylation. These amino acids are readily incorporated into peptides for a range of different applications.

First claim

Opening claim text (preview).

The invention claimed is: 1. An amino acid selected from the group consisting of: wherein: R 1 is selected from the group consisting of hydrogen, allyloxycarbonyl, t-butoxycarbonyl, benzyloxycarbonyl, fluorenylmethyloxycarbonyl, trityl, 4-methyltrityl, 4-methoxytrityl, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl, and 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl; R 2 is selected from the group consisting of hydrogen, hydroxyl, alkyl of 1 to 5 carbons, benzyl, succinamide, 4-nitrophenyl, and pentafluorophenyl; R 3 and R 4 are independently selected from the group consisting of hydrogen, —(CH 2 CH 2 O)mR 6 and —(CH 2 ) p R 7 ; R 5 is —(CH 2 CH 2 O) m R 6 ; R 6 is selected from the group consisting of alkyl of 1 to 5 carbons and —(CH 2 ) p R 7 ; m is an integer of 1 to 25; p is an integer of 1 to 10; and R 7 is selected from the group consisting of allyloxycarbonylamine, t-butoxycarbonylamine, benzyloxycarbonylamine, fluorenylmethyloxycarbonylamine, tritylamine, 4-methyltritylamine, 4-methoxytritylamine, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethylamine, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutylamine, hydroxyl, methoxy, tert-butoxy, benzyloxy, trityloxy, cholesteroloxy, acetate, carboxylic acid, methyl ester, tert-butyl ester, benzyl ester, azide, alkyne, biotin, biotinamide, cholesterol and fluorescent molecules; and X 1 is a counterion to balance the charge; and wherein: R 8 is selected from the group consisting of hydrogen, allyloxycarbonyl, t-butoxycarbonyl, benzyloxycarbonyl, fluorenylmethyloxycarbonyl, trityl, 4-methyltrityl, 4-methoxytrityl, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl, and 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl; R 9 is selected from the group consisting of hydrogen, hydroxyl, alkyl of 1 to 5 carbons and benzyl; R 10 represents a chemical bond or is selected from the group consisting of —NH(CH 2 ) q —where q is an integer of 1 to 10 and —NHCH 2 CH 2 (OCH 2 CH 2 ) r — where r is an integer of 1 to 10; R 11 and R 12 represent a lone pair of electrons otherwise R 11 and R 12 are independently selected from the group consisting of a hydrogen, —(CH 2 CH 2 O) s R 14 and —(CH 2 ) t R 15 ; R 13 is —(CH 2 CH 2 O) s R 14 ; R 14 is selected from the group consisting of alkyl of 1 to 5 carbons and —(CH 2 ) t R 15 ; s is an integer of 1 to 25; t is an integer of 1 to 10; and R 15 is selected from the group consisting of allyloxycarbonylamine, t-butoxycarbonylamine, benzyloxycarbonylamine, fluorenylmethyloxycarbonylamine, tritylamine, 4-methyltritylamine, 4-methoxytritylamine, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethylamine, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutylamine, hydroxyl, methoxy, tert-butoxy, benzyloxy, trityloxy, cholesteroloxy, acetate, carboxylic acid, methyl ester, tert-butyl ester, benzyl ester, azide, alkyne, biotin, biotinamide, cholesterol and fluorescent molecules; and X 2 is a counterion to balance the charge if necessary. 2. The amino acid of claim 1 wherein R 1 is selected from the group consisting of hydrogen, t-butoxycarbonyl, fluorenylmethyloxycarbonyl and benzyloxycarbonyl. 3. The amino acid of claim 1 wherein R 2 is selected from the group consisting of hydrogen, hydroxyl, methyl, ethyl, t-butyl, benzyl, succinamide, 4-nitrophenyl, and pentafluorophenyl. 4. The amino acid of claim 3 wherein R 2 is hydroxyl. 5. The amino acid of claim 1 wherein R 6 is methyl. 6. The amino acid of claim 1 wherein at least two of R 3 , R 4 and R 5 are the same. 7. The amino acid of claim 6 wherein at least two of R 3 , R 4 and R 5 are —(CH 2 CH 2 O) m CH 3 wherein m is 1 to 3. 8. The amino acid of claim 1 wherein at least two of R 3 , R 4 and R 5 are —(CH 2 CH 2 O) m R 6 wherein m is 1 to 4. 9. The amino acid of claim 8 wherein R 6 is —(CH 2 ) t R 7 wherein t is an integer of 2 to 4 and R 7 is selected from the group consisting of allyloxycarbonylamine, t-butoxycarbonylamine, tritylamine, 4-methyltritylamine, 4-methoxytritylamine, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethylamine, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutylamine, azide, alkyne, biotinamide and fluorescent molecules. 10. The amino acid of claim 1 wherein R 8 is selected from the group consisting of hydrogen, t-butoxycarbonyl, fluorenylmethyloxycarbonyl and benzyloxycarbonyl. 11. The amino acid of claim 1 wherein R 9 is selected from the group consisting of hydrogen, methyl, ethyl, t-butyl, and benzyl. 12. The amino acid of claim 1 wherein R 9 is hydroxyl. 13. The amino acid of claim 1 wherein R 10 represents a chemical bond. 14. The amino acid of claim 1 wherein R 10 is —NHCH 2 CH 2 —. 15. The amino acid of claim 1 wherein at least two of R 11 , R 12 and R 13 are the same. 16. The amino acid of claim 15 wherein at least two of R 11 , R 12 and R 13 are —(CH 2 CH 2 O) s CH 3 wherein s is 1 to 3. 17. The amino acid of claim 1 wherein at least two of R 11 , R 12 and R 13 are —(CH 2 CH 2 O) s R 14 wherein s is 1 to 4. 18. The amino acid of claim 17 wherein R 14 is —(CH 2 ) t R 15 wherein t is an integer of 2 to 4 and R 15 is selected from the group consisting of allyloxycarbonylamine, t-butoxycarbonylamine, tritylamine, 4-methyltritylamine, 4-methoxytritylamine, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethylamine, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutylamine, azide, alkyne, biotinamide and fluorescent molecules. 19. A method for forming a peptide comprising: providing a first PEGylated amino acid selected from the group consisting of: wherein: R 1 is selected from the group consisting of hydrogen, allyloxycarbonyl, t-butoxycarbonyl, benzyloxycarbonyl, fluorenylmethyloxycarbonyl, trityl, 4-methyltrityl, 4-methoxytrityl, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl, and 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl; R 2 is selected from the group consisting of hydrogen, hydroxyl, alkyl of 1 to 5 carbons, benzyl, succinamide, 4-nitrophenyl, and pentafluorophenyl; R 3 and R 4 are independently selected from the group consisting of hydrogen, —(CH 2 CH 2 O) m R 6 and —(CH 2 ) p R 7 ; R 5 is —(CH 2 CH 2 O) m R 6 ; R 6 is selected from the group consisting of alkyl of 1 to 5 carbons and —(CH 2 ) p R 7 ; m is an integer of 1 to 25; p is an integer of 1 to 10; and R 7 is selected from the group consisting of allyloxycarbonylamine, t-butoxycarbonylamine, benzyloxycarbonylamine, fluorenylmethyloxycarbonylamine, tritylamine, 4-methyltritylamine, 4-methoxytritylamine, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethylamine, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutylamine, hydroxyl, methoxy, tert-butoxy, benzyloxy, trityloxy, cholesteroloxy, acetate, carboxylic acid, methyl ester, tert-butyl ester, benzyl ester, azide, alkyne, biotin, biotinamide, cholesterol and fluorescent molecules; and X 1 is a counterion to balance the charge;

Assignees

Inventors

Classifications

  • to carbon atoms of hydrocarbon radicals substituted by carboxyl groups · CPC title

  • Peptides of undefined number of amino acids; Derivatives thereof · CPC title

  • having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups (peptides C07K) · CPC title

  • C07K1/066Primary

    for omega-amido functions · CPC title

  • having more than one amino group bound to the carbon skeleton, e.g. lysine · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10280194B2 cover?
Novel synthesized amino acids of glutamine and lysine that are directly PEGylated with small, monodisperse PEGs, and a novel process for creating novel amino acid monomers using PEGylation. These amino acids are readily incorporated into peptides for a range of different applications.
Who is the assignee on this patent?
Univ Clemson
What technology area does this patent fall under?
Primary CPC classification C07K1/066. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).